Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Project Findings To ‘Instil Confidence’ In Using Patient Preference Studies

Executive Summary

The European Medicines Agency’s endorsement of a framework that explains how drug and medical device sponsors can use patient preference studies to answer their research questions could help increase confidence in the conduct and acceptability of such studies.

You may also be interested in...



Guidance On Harmonization Of Patient-Focused Drug Development Is Years Away

The International Council for Harmonization has proposed topics for a global PFDD guideline and is expected to begin work on it in the next few years. When finalized, the US FDA will issue it as draft guidance.

EMA Consults On Proposed Framework For Patient Preference Studies

The EMA is inviting feedback on its plans to ratify, with some caveats, a new framework on how to use patient preferences as input in medical product decision-making. The framework was developed under the EU’s public-private Innovative Medicines Initiative.

Saudi FDA Finalizes Approach To Commercial Info In Public Assessment Reports

Saudi Arabia has explained what information on a drug’s review will be made public following a marketing authorization decision. 

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS146341

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel